We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Schoolmates is an excellent social networking platform created by Chris Goodwin (CEO and Founder). There are about 32,000 educational establishments enlisted on Schoolmates’ website. It is an easy-to-use free networking platform to connect with old and new friends. It caters to 25+ (age group) representing 50% of the UK population.
days to go: Expired investment: £16,410
People spend more on activities for their children than electricity or holidays. KalliKIds makes sure they spend wisely, picking classes, places to go and services they can trust: Trip Advisor or Go Compare for kids with up-front checking. Parents get to know the best choices and discounts and the activity providers get promoted. KalliKids has 670 providers, a renewal rate of >70% and providers signing up for a third year. The website has smashed its five year targets with 27k hits/month.
days to go: Expired investment: £174,946
Receive an affordable massage at home and on-demand by easily booking straight from an app. Since the start of year, Urban Massage has delivered more than 114,000 massages and received a 4.85/5 or above rating for the level of treatment provided to their customers. The company has successfully launched in Birmingham, Manchester and Paris with an Annualised Run Rate (ARR) of 3,300% from June 2014 and in June 2018, an ARR of £10.4m.
days to go: Expired investment: £3,491,730
A new social media platform created for parents, by parents. TotsApp allows parents to arrange babysitters and school-lifts for their children, as well as socialise and share interesting offers and holidays they find with their groups or with the wider community. Parents can also list unwanted children's toys and items for other users to purchase.
days to go: Expired investment: £32,290
The Gut Stuff is a proactive advocate for gut health, educating a substantial community and offering an innovative app in BETA that aims to bridge gaps in the gut health market. With a strong presence in physical products, workplace education, and media, they're positioned to redefine the gut health category and leverage diversified revenue streams for growth during their expansion into the digital realm.
days to go: Expired investment: £321,662
Fore Fitness Group (FFG) is a company that operates the easyGym and PACK45 brands in the fitness space. It operates 20 affordable but high-quality easyGym units across 3 countries. FFG plans to open gyms, boutique studios across the world and develop digital assets such as workout apps. It is developing two new products: an innovative workout app, and an effective & easy-to-use home fitness equipment machine. FFG believes that these steps will appeal to fitness enthusiasts both during and after the Covid-19 pandemic. FFG’s’ vision is to operate the largest fitness network in the world by 2030. The company will use the investment: 10% of it to patent, prototype and gather initial feedback for the home fitness equipment, 20% to build, market and ship the first orders for the home fitness equipment, 15% to market and establish momentum for the workout app, 15% to launch a premium version of the online fitness library, 20% for company costs such as rent and staffing, and the rest for investment opportunities that may present themselves and to seek new Master Franchise Agreements (MFAs) for different countries with eligible partners.
days to go: Expired investment: £1,462,390
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £290,278
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph